Nikki Heron is the Vice President of Finance at VitriVax and a seasoned finance executive with over 25 years of experience in both public and private companies. She has deep knowledge of the biopharmaceutical industry, particularly in preclinical and drug development start-ups. Nikki has a proven track record in corporate finance, equity financing, strategic planning, financial analysis, cash flow optimization, corporate operations, alliance management, and M&A. Throughout her career, Nikki has facilitated significant transactions, including the sale of rPath Inc. to SAS Software in 2012. More recently, she played a critical role in the partnership between Tavros Therapeutics and Vividion Therapeutics, a wholly owned subsidiary of Bayer, which led to Tavros’s successful acquisition by Vividion in 2024. She also spent more than a decade as a fractional CFO, supporting over two dozen start-ups, primarily in the biotech sector. Nikki is a CPA and holds a Bachelor of Business Administration in Accounting from James Madison University.